Vanguard Fiduciary Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Vanguard Fiduciary Trust's BMY Position: Q2 2026 in Review
Vanguard Fiduciary Trust reduced its Bristol-Myers Squibb (BMY) stake by 0.43% in Q2 2026, selling an estimated $2.83M and leaving 11,467,840 shares worth $661M. The position accounts for 0.15% of the portfolio, ranked #114.
Vanguard Fiduciary Trust first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $699M in Q1 2026. 2,488 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Vanguard Fiduciary Trust held 11,467,840 shares of Bristol-Myers Squibb worth $661M as of Q2 2026.
- Vanguard Fiduciary Trust sold 49,364 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.83M.
- Bristol-Myers Squibb made up 0.15% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #114 holding.
- Vanguard Fiduciary Trust first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Vanguard Fiduciary Trust's Bristol-Myers Squibb position peaked at $699M in Q1 2026.
- 2,488 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.